MicroRNA155 mediates adverse inflammation in acute viral myocarditis LNA-antimiR155 treatment

ABSTRACT: For microRNA knockdown in vivo, a 15-mer LNA-antimiR oligonucleotide targeting mmu-miR-155 or an LNA control was administered to male 4-week-old C3H mice intravenously at a dose of 25 mg/kg per injection at days 1, 4 and 6 post-CVB3 infection. Samples were taken at 6 days post infection.

ORGANISM(S): Mus musculus

DISEASE(S): viral myocarditis

SUBMITTER: Maarten Corsten 

PROVIDER: E-MEXP-3395 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress